Related Experiment Video

Updated: Jan 17, 2026

Overexpressing and Purifying a Toxic Nuclease from Escherichia coli
08:13

Overexpressing and Purifying a Toxic Nuclease from Escherichia coli

Published on: August 29, 2025

709

Inhibitory effects against SARS-COV-2 main protease of terpenic substances and selenated naphthoquinones

Marcos R Scheide1, Tiago Tizziani1, Gabriella B Souza1

  • 1Department of Chemistry, Federal University of Santa Catarina, Florianópolis, SC, Brazil.

Natural Product Research
|September 21, 2025
PubMed

Keywords:
SARS-CoV-2naphtoquinonesproteaseseleniumterpenic coumponds

More Related Videos

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation07:53

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation

Published on: January 9, 2019

33.8K
Engineering Antiviral Agents via Surface Plasmon Resonance13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.7K

Related Concept Videos

Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.6K
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.5K